Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Lance Scott (NPI 1417958059)

Field	Value
Entity Type	Individual
Organization	Lance Scott
Address	9821 S May Ave Ste C
City	Oklahoma City
State	OK
ZIP	73159
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 4, 2005

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: lifetime Medicare revenue is $3.7M while Medicaid revenue is listed as none (no Medicaid billing on file). The absence of Medicaid activity means the practice’s entire recorded public‑payer footprint is concentrated in Medicare, which raises exposure to Medicare policy and reimbursement changes.

Revenue concentration is high: the precomputed top‑3 Medicare codes by revenue account for 72.6% of this provider's total Medicare revenue. Those top three codes are J2777 (55K claims, $29 avg paid/claim, $1.6M revenue, 43.1%), J2778 (3.8K claims, $182 avg paid/claim, $696.5K revenue, 18.8%), and J0178 (584 claims, $680 avg paid/claim, $397.1K revenue, 10.7%).

The code mix indicates a retina‑focused ophthalmology operation that runs a high‑volume intravitreal injection service alongside substantial diagnostic imaging and some surgical retina work. The practice’s three highest revenue drivers are intravitreal drug codes (J2777, J2778, J0178), and additional activity in retinal imaging and follow‑up visits — for example, 92134 (3.5K claims, $28 avg paid/claim, $99.2K revenue) and 92014 (2.3K claims, $81 avg paid/claim, $185K revenue) — supports an ambulatory retina clinic model.

This provider is a nationally high‑volume operator for several retina and imaging services: J2777 ranks #87 of 2039 (96th percentile) and is described as notably above typical national volume, J2778 ranks #76 of 1208 (94th percentile), and 92014 ranks #158 of 35415 (100th percentile) and is an extreme outlier. In addition, 92134 ranks #217 of 26868 (99th percentile) and 67028 ranks #203 of 4255 (95th percentile), showing the provider is a major contributor to Medicare volumes for both intravitreal therapy and retinal diagnostic procedures.

Not all high‑revenue codes are high percentile performers: J0178 (584 claims, $680 avg paid/claim, $397.1K revenue) ranks #1799 of 3204 (44th percentile) and is described as typical/unremarkable, and several drug and ancillary codes such as J3490 (103 claims, $1724 avg paid/claim, $177.6K revenue) are characterized as typical or unremarkable in national rank. This mixed profile suggests the practice combines nationally exceptional volume in a few specific codes with more typical participation in other therapeutic agents and miscellaneous drug billing.

Operationally, the injection mix shows very different unit economics across products: J2777 has very high volume but a low average paid per claim ($29 avg paid/claim for J2777) while J0178 shows a much higher average paid per claim ($680 avg paid/claim for J0178) with far fewer claims. That pattern implies revenue and cash flow are driven by both drug choice and throughput — high counts of lower‑paid units plus smaller counts of higher‑paid biologic units — which has implications for drug purchasing, inventory, and reimbursement sensitivity.

The provider demonstrates longstanding activity: NPI enumerated 2005-08-04 (~21 years ago), indicating more than two decades of potential practice history under the NPI and likely established referral and patient workflows. That tenure, combined with extreme outlier volumes on multiple imaging and exam codes, supports the characterization of an established retina/ophthalmology practice rather than a new entrant.

From a payer and network perspective, the complete lack of Medicaid billing on file reduces the provider’s applicability for Medicaid‑focused networks and population health strategies; conversely, the strong Medicare footprint and top‑percentile ranks on retina injections and imaging position the provider as an attractive high‑volume partner for Medicare ACOs, specialty networks, and value‑based arrangements focused on eye care.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	55,020	$30	$1.6M
J2778	Injection, ranibizumab, 0.1 mg	3,830	$180	$696.5K
J0178	Injection, aflibercept, 1 mg	580	$680	$397.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,430	$80	$197K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,280	$80	$185K
J3490	Unclassified drugs	100	$1,720	$177.6K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	770	$220	$168.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,540	$30	$99.2K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	320	$160	$50.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	380	$120	$45K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Lance Scott — 5 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	21	30	790	$690	$801.2K
J2777	3	20	23,040	$30	$781.1K
Q5128	3	10	800	$220	$182.2K
J2778	1	10	420	$180	$173.2K
67028	4	40	720	$80	$88.9K
J2781	3	10	380	$120	$67.4K
Q5124	1	10	220	$160	$34.4K
J3490	7	30	70	$320	$24.6K
J9035	19	30	330	$50	$23.5K
67036	6	10	20	$900	$19.9K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Lance Scott, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jordan Johnson	OK	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Vinay Shah	OK	Retina Specialist (Ophthalmology) Physician	$1.7M	$0
Brian Firestone	OK	Ophthalmology Physician	$228.5K	$0

Nearby Providers

Other providers in the same ZIP code as Lance Scott, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Little Hands Little Voices	OK	Speech-Language Pathologist	$0	$5.3M
Brandi Kammerer PLLC	OK	Family Nurse Practitioner	$0	$4.8M
Es Speech LLC	OK	Speech-Language Pathologist	$0	$4M
Fountain Of Hope Family Services, Inc.	OK	Community/Behavioral Health Agency	$0	$3M
Community Hospital LLC	OK	General Acute Care Hospital	$0	$2.6M
Weir Asc, LLC	OK	Ambulatory Surgical Clinic/Center	$1.9M	$461.3K
Board Of Regents Of The University Of Oklahoma-ou Physicians	OK	Primary Care Clinic/Center	$0	$2M
Senthil Palaniappun	OK	Vascular & Interventional Radiology Physician	$600K	$0
Danh Pham	OK	Family Medicine Physician	$546.1K	$0
Darryl Robinson	OK	Physical Medicine & Rehabilitation Physician	$222.3K	$0

Lance Scott — Billing Profile & Reimbursement Data

Sign up for Lance Scott — Billing Profile & Reimbursement Data policy alerts

Lance Scott — Billing Profile & Reimbursement Data

Sign up for Lance Scott — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References